Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates
AssigneeProteinSimple
InventorJiaqi Wu
Life of this patent
Estimating the term…
Loading patent…
AssigneeProteinSimple
InventorJiaqi Wu
Estimating the term…
Provided herein are IEF focusing methods for determining the number of drug molecules present in at least one antibody-drug conjugate (ADC) species subpopulation. In one embodiment, the method comprises performing free solution isoelectric focusing on a sample comprising at least one ADC species, to obtain a focused sample. The absorbance of the sample at two different wavelengths is then measured, for example, over a range of pI values. Absorbance values at the two different wavelengths are compared at at least one corresponding pI value, where the at least one corresponding pI value is the pI of the ADC subpopulation. The number of drug molecules in the at least one ADC species subpopulation is then determined based on the comparison. The methods provided herein can also be used to determine the number of specific binding pair members bound to its target specific binding pair member.
A method for determining a number of drug molecules present in an antibody-drug conjugate (ADC) species subpopulation, in a sample comprising at least one ADC species, comprising:
A method for determining a number of specific binding pair members bound to a target specific binding pair member in a sample comprising at least one specific binding pair, comprising:
A method for determining a number of drug molecules in at least two ADC subpopulations in a sample comprising at least one ADC species population, comprising:
Dependencies are inferred from the claim text.